Literature DB >> 22133619

Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis.

Kati P Markula-Patjas1, Helena L Valta, Liisa I Kerttula, Irma H Soini, Visa E A Honkanen, Sanna-Maria Toiviainen-Salo, Outi M Mäkitie.   

Abstract

OBJECTIVE: Vertebral fractures occur in patients with juvenile idiopathic arthritis (JIA), but data on their frequency and causes are scarce. Our cross-sectional study evaluated prevalence of compression fractures and associated factors in a high-risk pediatric population with severe JIA.
METHODS: Children and adolescents with a history of treatment-resistant polyarticular-course JIA for ≥ 5 years or systemic arthritis for ≥ 3 years were recruited. Clinical examination, dietary recall, laboratory measurements, bone mineral density (BMD) measurement by dual-energy X-ray absorptiometry, and spinal radiography were performed.
RESULTS: Our study included 50 patients (41 girls), of whom 6 (12%) had systemic arthritis, with a median age of 14.8 years (range 7.0-18.7 yrs) and median disease duration of 10.2 years (range 3.9-16.8 years). Ninety-four percent had used systemic glucocorticoids (GC); the median total duration of GC treatment was 7.1 years (range 0-15.5 yrs). The median weight-adjusted cumulative GC dose for the preceding 3 years was 72 mg/kg (range 0-911 mg/kg). The median bone age-corrected lumbar spine and whole-body areal BMD Z-scores were -0.8 and -1.0, respectively. Twenty-two percent had vertebral fractures, mostly thoracic. Compression fractures were associated with high disease activity, high body mass index (BMI), and high recent cumulative GC dose, but not with disease duration or BMD. Thirty percent had sustained at least 1 peripheral low energy fracture. Twenty-six percent were deemed to have significantly compromised bone health.
CONCLUSION: Severe JIA is associated with a significant risk of vertebral compression fractures. Associated factors include high disease activity, high BMI, and high recent GC exposure. Further studies are needed to establish optimal prevention and treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133619     DOI: 10.3899/jrheum.110305

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Diagnosis of Osteoporosis in Children and Adolescents.

Authors:  Christine M Laine; Tero Laine
Journal:  Eur Endocrinol       Date:  2013-08-23

Review 2.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

3.  Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.

Authors:  Claire M A LeBlanc; Jinhui Ma; Monica Taljaard; Johannes Roth; Rosie Scuccimarri; Paivi Miettunen; Bianca Lang; Adam M Huber; Kristin Houghton; Jacob L Jaremko; Josephine Ho; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; Robert Stein; Anne Marie Sbrocchi; Kiem Oen; Celia Rodd; Roman Jurencak; Elizabeth A Cummings; Robert Couch; David A Cabral; Stephanie Atkinson; Nathalie Alos; Frank Rauch; Kerry Siminoski; Leanne M Ward
Journal:  J Bone Miner Res       Date:  2015-05-26       Impact factor: 6.741

Review 4.  Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.

Authors:  Francesca Di Marcello; Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 5.  Causes, mechanisms and management of paediatric osteoporosis.

Authors:  Outi Mäkitie
Journal:  Nat Rev Rheumatol       Date:  2013-04-16       Impact factor: 20.543

Review 6.  Long-term bone health in glucocorticoid-treated children with rheumatic diseases.

Authors:  Isabelle Rousseau-Nepton; Bianca Lang; Celia Rodd
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

Review 7.  New Insights Into Monogenic Causes of Osteoporosis.

Authors:  Riikka E Mäkitie; Alice Costantini; Anders Kämpe; Jessica J Alm; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-25       Impact factor: 5.555

8.  Bone mass and vertebral fractures in South African children on prolonged oral glucocorticoids for chronic non-malignant illnesses.

Authors:  Kebashni Thandrayen; Udai Keshav Kala; Nilesh Lala; Grace Okudo; Kiran Bhagoo Parbhoo; Fatima Yakoub Moosa; Charl Verwey; Marc Hauptfleisch; Christina Hajinicolaou; Priya Ramanlal Ambaram; Bhadrish Jayantkumar Mistry; Karen Lavinia Petersen; John Morley Pettifor
Journal:  Bone Rep       Date:  2021-02-02

Review 9.  Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jing-Long Huang; Jenn-Haung Lai
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

Review 10.  Vitamin D and juvenile idiopathic arthritis.

Authors:  Sarah L Finch; Alan M Rosenberg; Hassan Vatanparast
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-16       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.